Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - March 2014

3-day Mass Spectral Interpretation training course

25 Mar 2014 - 27 Mar 2014 - Milton Keynes, UK

Bookmark and Share

This course is an introduction to mass spectral interpretation, aimed at presenting the fundamental tools and rules when examining high quality full-scan GC-MS data. Every analyst using GC-MS should have a fundamental understanding of how a mass spectrum is generated and if a library match is correct or not. This course takes this a step further to enhance mass spectral knowledge. From learning to quickly recognise from the spectrum if the analyte is aliphatic or aromatic in nature; to learning to interpret the number of carbon atoms, heteroatoms and degree of unsaturation; and understand isotopes, isomers, logical losses, cleavages and rearrangements to produce a mass spectral fingerprint of the compound. This course is classroom based and combines powerpoint presentations to introduce the theory with a high proportion of exercises on spectral data to reinforce the topics learned. Anyone wishing to learn the fundamentals of mass spectral interpretation for the identification of unknowns or to enhance their understanding of fragmentation patterns produced from GC-MS analysis to aid in accurate identification when using library search programs. This course is recommended for those who have a good background in organic chemistry and at least six months GC-MS experience.

Further information
Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Influential Cancer Researcher Receives Agilent Thought Leader Award
Biologist Scott Lowe receives award in recognition for his contributions to cancer biology.
Gene-Editing Cures Genetic Blood Disorder in Mice
New technology may offer minimally invasive treatment for genetic disorders of the blood.
ALS Study Reveals Role of RNA-Binding Proteins
The findings are a significant step forward in validating RNA-based therapy as a treatment for ALS.
New Compound Shows Promise in Treating Multiple Human Cancers
The research presents a new way to efficiently kill these cancerous cells and holds promise for the treatment of all cancers.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
IU Research Reveals Link between Molecular Mechanisms in Prostate Cancer and Ewing's sarcoma
Researchers at IU have suggested that the molecular mechanism that triggers the rare disease Ewing's sarcoma could act as a potential new direction for the treatment of more than half of patients with prostate cancer.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos